文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with fusion transcript.

作者信息

Fazio Francesca, Barberi Walter, Cazzaniga Gianni, Fazio Grazia, Messina Monica, Della Starza Irene, De Propris Maria Stefania, Mancini Francesca, Mohamed Sara, Del Giudice Ilaria, Chiaretti Sabina, Moleti Maria Luisa, Guarini Anna, Foà Robin, Testi Anna Maria

机构信息

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.

Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.

出版信息

Leuk Lymphoma. 2020 Feb;61(2):469-472. doi: 10.1080/10428194.2019.1668938. Epub 2019 Sep 27.

DOI:10.1080/10428194.2019.1668938
PMID:31558067
Abstract
摘要

相似文献

[1]
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with fusion transcript.

Leuk Lymphoma. 2020-2

[2]
Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion.

Ann Hematol. 2021-5

[3]
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

Blood. 2016-2-12

[4]
[Acute lymphoblastic leukemia with EBF1-PDGFRB fusion gene: two cases report and literature review].

Zhonghua Xue Ye Xue Za Zhi. 2023-1-14

[5]
B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.

J Pediatr Hematol Oncol. 2021-1

[6]
Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.

Acta Haematol. 2019-2-6

[7]
Early diagnosis of EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Pediatr Int. 2022-1

[8]
Acute Lymphoblastic Leukemia Patient with Variant ATF7IP/PDGFRB Fusion and Favorable Response to Tyrosine Kinase Inhibitor Treatment: A Case Report.

Am J Case Rep. 2017-11-14

[9]
ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.

Br J Haematol. 2014-3-15

[10]
Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion.

Haematologica. 2013-11

引用本文的文献

[1]
The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.

J Cell Mol Med. 2024-2

[2]
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity : A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias.

Front Pharmacol. 2021-11-19

[3]
Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?

Best Pract Res Clin Haematol. 2021-12

[4]
Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.

Genes (Basel). 2021-5-1

[5]
Interstitial Deletions Generating Fusion Genes.

Cancer Genomics Proteomics. 2021

[6]
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.

Haematologica. 2021-6-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索